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Abstract  
Introduction: Chronic kidney disease (CKD) is an emerging worldwide epidemic but few data are available in African populations. We aimed to 
assess prevalence of CKD in adult populations of Saint-Louis (northern Senegal). Methods: In a population-based survey between January and 
May 2012, we included 1,037 adults aged =18 years living in Saint-Louis. Socio-demographical, clinical and biological data were collected during 
household visits. Serum creatinine was measured by Jaffé method. We estimated glomerular filtration rate (eGFR) using the 4-variables MDRD 
equation and CKD was defined by eGFR < 60 mL/min/1.73m2 and/or albuminuria > 1g/L. A multivariate logistic regression was performed to 
identify factors associated with CKD. Results: Mean participants  age was 47.9 ±16.9 years (18-87) and sex-ratio was 0.52. Majority of 
participants lived in urban areas (55.3% rural) and had school education (65.6%). Overall prevalences of hypertension, diabetes and obesity were 
39.1%, 12.7% and 23.4% respectively. Prevalence of CKD was 4.9% (95% CI= 3.5   6.2) and 0.9% had GFR < 30 mL/min/1.73m2. Albuminuria 
>1g/l was found in 3.5% of people. CKD was significantly more frequent among hypertensive patients compared to normotensive participants. 
Only 23% of patients were aware of their disease before the survey. After multivariate logistic analysis, presence of CKD was significantly 
associated with hypertension (OR=1.12, p= 0.02) and age (OR=1.03, p= 0.02). Conclusion: CKD is frequent in adult population living Northern 
Senegal. Main associated factors are hypertension and age. Prevention strategy is urgently needed to raise awareness and promote CKD detection 
and early treatment in both urban and rural areas. 
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Chronic kidney disease (CKD) represents one of the greatest public 
health challenges in the 21st century and is associated with an 
important cardiovascular morbidity and mortality [1, 2]. It has a 
major impact on healthcare costs and world productivity particularly 
in low-income countries where the young people are the most 
concerned [3]. Early detection combined with an adequate 
management of patients are the best strategy to fight this disease. 
In Africa, though we assist to a rising awareness of health 
authorities about CKD burden, prevention and management 
programs are still difficult to elaborate because of the scarcity of 
epidemiological data at population level [3, 4]. Most of current data 
come from nephrology departments in specialized hospitals in big 
cities and there is very little information in rural populations [5].  
 
This study aimed to assess prevalence of chronic kidney disease 






Study design: We performed a community-based cross-sectional 
survey in Saint-Louis (northern region of Senegal). All individuals 
aged =18 years and living in Saint-Louis since at least 3 months 
were eligible to participate in the study.  
 
Sampling procedure: A two-stage cluster sampling method was 
used to select a representative sample of adults living in urban and 
rural areas of Saint-Louis. We firstly selected 17 localities as clusters 
(9 urban areas and 8 rural areas). Then, we randomly took a 
number of households proportionally to population size of each 
locality (data available from the National Agency of Statistics and 
Demography). From each household a maximum of two participants 
were recruited.  
 
Considering a a-error of 0.05 and a power ^6; of 80%, the required 
sample size was 855 individuals and we added a 20% attrition rate 
to get a final sample of 1026 participants.  
 
Data collection: Data were collected on-site during house-to-
house visits that were conducted between 7a.m. and 12 a.m. or at 
the nearest health centre when patients did not live far away from 
this facility.  
 
A modified version of the WHO STEPS wise questionnaire was pre-
tested and validated before its use to collect data. Researchers 
assisted by medical students, trained nurse practitioners, and 
community health workers had to fill the data collection form, to 
document the socio-demographic status (age, sex, marital status, 
education, profession and education), personal and family health 
history (regarding particularly hypertension, diabetes, stroke, heart 
and kidney disease), and lifestyle (nutritional habits, physical 
activity, smoking and alcohol consumption) of each participant. 
History of nephrotoxic medications (non-steroidal anti-inflammatory 
drugs and traditional herbs) was also assessed. Anthropometric 
measurements (weight, height, waist and hip circumference) were 
performed using standard methods and calibrated devices. Serum 
total cholesterol, LDL cholesterol, HDL cholesterol, and Triglycerides 
were measured with colorimetric method. Obesity was defined using 
International Diabetes Foundation cut-offs [6]. Blood pressure was 
measured twice at five minutes intervals by a semiautomatic 
sphygmomanometer and the mean of the two readings was 
calculated. If the difference between the readings was greater than 
10 mm Hg, a third measurement was performed.  
Hypertension was defined as a systolic blood pressure of 140 mm 
Hg or more, diastolic blood pressure of 90 mm Hg, any prescription 
of antihypertensive medication in the past two weeks, or any self-
reported history of hypertension [7]. Fasting blood glucose (FBG) 
was measured with a glucose oxidase method. Diabetes was 
defined as FBG = 1.26 mg/dL, by prescription of hypoglycemic 
agents despite fasting plasma glucose, or any self-reported history 
of diabetes [6].  
 
Physical inactivity was defined as less than 30 minutes of moderate 
activity per week or less than 20 minutes of vigorous activity three 
times per week, or the equivalent.  
 
Serum creatinine was measured with Jaffe s kinetic method and 
glomerular filtration rate (GFR) was estimated with the MDRD 
equation [8]. Urinary albumin excretion (UAE) was first screened 
using strips and positive cases were confirmed by a quantitative 
dosage in the 24 hours urine output. CKD was defined according to 
National Kidney Foundation classification [9].  
 
Ethical issues: The study was approved by the National 
Committee for Ethics in Health Research. A free consent form had to 
be signed by participants to give their approval before data 
collection. All participants were personally informed of their 
screening results and those with abnormal values were referred to a 
specialist for further exploration and treatment.  
 
Statistical analysis: Statistical analyses were performed with 
STATA 12.0 (Stata Corp, TX, USA). Continuous variables were 
presented as mean ± standard deviation and categorical variables 
as percentage. Comparison of proportions and means were done 
using Pearson s Chi-square test or Student s t-test as 
appropriated. Multivariate regression analysis was used to identify 
clinical and biological parameters associated with CKD. A p-value 





A total of 1047 individuals were interviewed and 1037 had a 
complete questionnaire and were kept in the study (response rate of 
99%).  
 
Fifty three percent of them lived in urban areas and 60% were 
female. Table 1 presents demographical, clinical and biological 
characteristics of participants according to their living areas. 
Compared to rural population, participants from urban cities were 
older, more educated, more active, and more likely to be women. 
One participant out of ten reported a relative with a history of renal 
disease. Cardiovascular risk factors such as hypertension, diabetes 
and obesity were frequent among the whole population with a 
significantly higher prevalence in individuals living in urban areas 
(Table 1).  
 
Overall adjusted prevalence of CKD in the total population was 
6.1% (95%confidence interval between 4.7% and 7.6%) with 3.5% 
of individuals presenting with albuminuria > 1g/L. Chronic kidney 
disease prevalence in women (5.7%) was lower than in men 
(6.9%). A linear increase with age was found in CKD prevalence (p 
for trend = 0.03). In the subgroup of people aged > 60 years, 
14.3% presented CKD (Figure 1).  
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Surprisingly, people living in rural areas showed a similar prevalence 
of CKD compared to those in urban cities (respectively 7.6% and 
5.0%, p=0.08) even though early stages 1 and 2 were more 
frequent in urban areas (Figure 2). Eighty three percent of people 
with CKD in rural areas and 62.7% in urban areas were not aware 
of their disease before the study.  
 
In the univariate analysis, CKD was significantly associated with 
hypertension, obesity, physical activity, familial history of kidney 
disease and age group (Table 2).  
 
After multivariate regression analysis, only age and high blood 
pressure remained significantly associated with CKD while diabetes, 
familial history and obesity failed to reach statistical significance 





This study is the first one that assessed in a sample of Senegalese 
population the burden of CKD particularly for the early stages (1 
and 2) which are often not seen by specialists at hospital [10]. 
Globally, prevalence of CKD is estimated to 10% but there are many 
variations between countries and within the same countries [11].  
In sub-Saharan Africa, epidemiology of CKD in general population is 
difficult to estimate because of possible confounding due to 
heterogeneity of study populations, design and methods used to 
define CKD (1). Community-based studies are very scarce and most 
of previously reported data come from hospital records [2, 3]. CKD 
prevalence in our population was lower than previous reports from 
community-based studies in Ghana (13.2%) [5] and Kinshasa 
(12.4%) [12]. This study also confirmed the increase of CKD 
prevalence with age already described in other populations [1, 3]. 
However, the level of increase was less important compared to US 
population where more than 20% of people aged >60 years have 
CKD [13].  
 
As expected, our results found less than one quarter of CKD 
patients who were aware of their disease particularly in rural areas 
were education level is lower and people do not easy access to 
healthcare services. Similar low rates of awareness had been 
commonly reported in other populations [14] and even health 
workers [15]. More efforts are needed to sensitize governments and 
populations about the disease burden [1].  
 
CKD risk factors like high blood pressure, diabetes, obesity and 
abdominal obesity were frequent among participants [2, 11]. 
However, only age and hypertension independently correlated with 
CKD while other risk factors. Some risk factors like infections, 
genetic predispositions and environmental or herbal toxins were not 
evaluated in this study but they might play a prominent role in 
African populations [16, 17].  
 
Interestingly, one CKD patient over nine in our study was detected 
at early stages where therapeutic interventions are most efficient [2, 
10]. In developing countries, diagnosis of patients at ESRD has a 
limited interest because a few proportions of them will have access 
to renal replacement therapy with a lot of difficulties [18].  
 
In order to achieve long-term reduction of CKD morbidity and 
mortality, early detection and prevention at population level are the 
best cost-effective strategy because conservative treatment has 
limited public health impact [2, 4, 19]. Developed countries spend 
2-3% of their health expenditures for management of ESRD patients 
who represent less than 0.03% of patients [20]. The situation is 
probably worse in low-income countries where healthcare 
expenditure is often very low and the majority of ESRD patients die 
because of dialysis inaccessibility [3].  
This study has many limits due to its cross-sectional design, 
inferences about causality or direction of association should be 
made with caution.  
 
Nevertheless, it gives an insight on the epidemic of CKD in the 
northern region of Senegal. More longitudinal studies are urgently 
needed to produce reliable data about CKD incidence, prevalence, 
and risk and progression factors in sub-Saharan African populations 
[1, 3]. Integrating CKD in other chronic diseases programs could be 
an interesting approach to increase coverage of screening and 
awareness in populations. However, mass screening might not be 
beneficial from a public health perspective because of potential 
overdiagnosis of cases that will undergo unnecessary investigation 
or referral to secondary care and the high cost for the healthcare 
system [21]. Also, cost-effectiveness of current preventive 
interventions should be assessed in relation to the local socio-





This study reveals a high prevalence of chronic kidney disease in 
northern region of Senegal. Urban and rural areas are similarly 
concerned and awareness rate is very low among populations. Early 
asymptomatic stages are the most frequent and associated risk 
factors are hypertension and aging. Integration of CKD screening to 
routine general medicine visits would improve early detection and 
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Figure 1: Prevalence of chronic kidney disease according to age 
groups 
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Table 1: Demographical and clinical characteristics of participants. (Data are expressed as mean ±standard deviation or number and 
percentage) 







Age (years) 48.0 ±16.9 (18-87) 51.6 ±15.7 43.5 ±17.2 0.001 
Age group       0.001 
18-34 years 25.6% 16.0% 37.8%   
35-49 years 25.3% 26.1% 24.2%   
50-60 years 23.6% 28.0% 18.1%   
>60 years 25.5% 29.9% 19.9%   
School education 60.7% 63.4% 55.6% 0.030 
Familial history of renal disease 10.4% 5.4% 15.0% 0.003 
Tobacco use 4.2% 5.2% 2.8% 0.094 
Alcohol use 4.5% 1.5% 8.5% <0.001 
Physical inactivity 58.1% 55.3% 61.7% 0.047 
Hypertension 39.1% 43.3% 33.8% 0.002 
Diabetes (FBG≥1.26g/l) 12.7% 14.6% 10.3% 0.038 
BMI (kg/m2) 26.3 ±6.8 27.9 ±7.3 24.3 ±5.5 <0.001 
Waist circumference 90.6 ±16.1 94.4 ±15.6 86.0 ±15.6 <0.001 
Obesity (BMI≥30 kg/m2) 23.4% 33.8% 10.2% <0.001 
Cholesterol (g/L) 2.18 ±0.49 2.25 ±0.54 2.10 ±0.44 <0.001 
SCr (mg/dl) 1.04 ±0.44 1.01 ±0.47 1.06 ±0.40 0.032 
eGFR (ml/min) 90.6 ±23.8 89.7 ±22.8 91.7 ±24.9 0.203 
Albuminuria>1g/l 5.3% 4.3% 6.6% 0.178 
BMI= body mass index; FBG= fasting blood glucose; SCr= serum creatinine; eGFR= estimated glomerular filtration rate according to 





Table 2: Association between chronic kidney disease and socio-demographical and clinical factors (univariate analysis) 
  Odds Ratio [95% Confidence Interval] p-value 
Age group 1.08 1.02 - 1.51 0.02 
Family history of renal disease 1.12 0.76 - 1.45 0.05 
School education 0.99 0.76 - 2.54 0.17 
Physical inactivity 0.65 0.57 - 0.99 0.05 
Hypertension 2.15 1.61 - 4.36 0.03 
Diabetes 1.22 0.33 - 40.74 0.63 
Obesity 1.33 1.05 - 1.98 0.04 






Table 3: Multivariate regression analysis of factors associated with chronic kidney disease 
  Odds Ratio [95% Confidence 
Interval] 
p-value 
Age group 1.03 1.00 - 1.06 0.018 
Hypertension  1.12 1.02 - 1.23 0.020 
Diabetes  0.80 0.25 - 2.51 0.703 
Family history of renal disease 1.43 0.38 - 5.33 0.597 
Obesity 0.77 0.24 - 2.46 0.662 
Urban (vs rural) residents 0.34 0.13 - 0.87 0.024 
School education 0.85 0.33 - 2.19 0.741 





















Figure 2: Level of glomerular filtration rate in urban and rural populations 
 
 
 
 
 
 
 
 
 
